Willow vs Regenics: Oral GLP-1 and Compounded GLP-1 Compared
Quick verdict: Willow vs Regenics differs mainly by care model and medication type. Willow centers on an oral GLP-1 program with structured progress tracking and clinician follow-up, while Regenics focuses on compounded semaglutide and tirzepatide with lower promotional entry pricing.
Explore Willow’s telehealth program
How they differ at a glance: care model, medication type, and pricing
This Willow vs Regenics comparison uses only the supplied evidence. The most distinctive differences supported by the sources are: care model and clinical team, medication format and regulatory notes, pricing structure and promotional details, added services and features, and pharmacy or fulfillment claims. Treatment eligibility for both is subject to a licensed clinician determining medical appropriateness, and both note that compounded medications are not FDA approved as finished products when offered.
Care model and clinical oversight
Willow: Telehealth-first weight management program emphasizing a licensed telehealth team, progress tracking tools, and follow-up consultations. The program frames itself as a structured weight management journey beyond medication alone.
Regenics: Care is delivered by licensed nurse practitioners who review intake before prescription. Regenics is described as nurse-practitioner-led telehealth GLP-1 care with a Sermorelin add-on option.
Medication format, regulatory notes, and pharmacy details
Willow: Positions an oral GLP-1 program. The source states that compounded medications, when offered, are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality.
Regenics: Offers compounded semaglutide and tirzepatide prepared by U.S. licensed compounding pharmacies and shipped to patients. The source repeats that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. Regenics also notes its pharmacy network is LegitScript certified in the captured evidence.
Pricing and promotional structure
Willow: Starting price evidence shows 299 as a starting price and price range/details listed as 299. The page captured returned an error and full pricing details beyond that starting figure were not verified on the captured page.
Regenics: Presents promotional first-month pricing in the captured evidence. Semaglutide starts at $139 first month with renewals noted at $199 per month, and tirzepatide starts at $189 first month with renewal at $279 per month, according to the supplied FAQ. Promotional pricing applies to the first month only and monthly cost increases on renewal were specifically noted.
Features, tracking, and added therapies
Willow: Emphasizes progress tracking tools and structured follow-up consultations as core to converting GLP-1 efficacy into sustainable outcomes for patients who want behavioral support beyond medication.
Regenics: Highlights access to compounded semaglutide and tirzepatide plus an optional Sermorelin peptide therapy for recovery, energy, and muscle support. Regenics also notes free shipping with medication compounded in the USA and that plans are FSA/HSA eligible in captured bullets.
| Criteria | Willow | Regenics |
|---|---|---|
| Care model | Licensed telehealth team; follow-up consultations | Licensed nurse-practitioner-led telehealth care |
| Medication type | Oral GLP-1 program; compounded meds note | Compounded semaglutide and tirzepatide; Sermorelin option |
| Starting price shown | Starting price 299 (captured) | Semaglutide $139 first month; tirzepatide $189 first month |
| Renewal pricing | Not verified on captured page | Semaglutide renews $199/mo; tirzepatide renews $279/mo per supplied FAQ |
| Pharmacy or shipping | Not verified on captured page | Compounded in the USA; free shipping noted |
| Regulatory note | Compounded medications not FDA approved when offered | Compounded medications not FDA approved when offered; pharmacy network LegitScript certified |
Clinical eligibility, safety framing, and what is not verified
Both sources state treatment is available only when a licensed clinician determines it is medically appropriate. Neither source provides captured evidence in this dataset about long term outcomes, specific medication dosing, shipping fees beyond Regenics free shipping claim, in-person clinic options, or cancellation terms for Willow. Where compounded medications are mentioned, both sources preserve the regulatory qualifier that these products are not FDA approved finished products and are not reviewed by FDA for safety, effectiveness or quality.
Compare Regenics pricing and meds
Conclusion: choose based on support versus low-entry compounded options
Willow vs Regenics comes down to whether you value structured behavioral follow-up around an oral GLP-1 program or a lower promotional cash-pay entry to compounded semaglutide or tirzepatide overseen by nurse practitioners. Both require clinician review and both note that compounded medications are not FDA approved as finished products.
Choose Willow if you want a telehealth-first program emphasizing progress tracking and follow-up consultations as part of a structured weight management journey.
Choose Regenics if you prefer nurse-practitioner-led telehealth access to compounded semaglutide or tirzepatide with promotional first-month pricing and optional Sermorelin peptide therapy.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →